Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1523 studies found for:    Recruiting | cancer | United States, Texas
Show Display Options
RSS Create an RSS feed from your search for:
Recruiting | cancer | United States, Texas
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Importance of Magnetic Resonance Imaging (MRI) in Treating Breast Cancer
Condition: Breast Cancer
Intervention: Procedure: MRI
2 Recruiting TDM1 With Abraxane and Lapatinib for Metastatic HER2 Positive Breast Cancer
Condition: Metastatic Breast Cancer
Interventions: Drug: TDM1;   Drug: Lapatinib;   Drug: Abraxane
3 Recruiting Enzalutamide and Hormone Therapy Before, During, and After Radiation for High Risk Localized Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Enzalutamide;   Drug: Leuprolide acetate;   Radiation: radiation
4 Recruiting Pilot Study of Durvalumab (MEDI4736) in Combination With Vigil™ in Advanced Breast Cancer
Condition: Triple Negative Breast Cancer
Interventions: Biological: Vigil™;   Drug: Durvalumab (MEDI4736)
5 Recruiting Stereotactic Ablative Body Radiation Therapy for Patients With Primary Renal Cancer
Condition: Renal Cancers
Intervention: Radiation: Stereotactic Ablative Radiation Therapy
6 Recruiting A First-in-Man, Phase I Evaluation of A Single Cycle of Prohibitin Targeting Peptide 1 in Patients With Metastatic Prostate Cancer and Obesity
Condition: Prostate Cancer
Intervention: Drug: Prohibitin-TP01
7 Recruiting Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Arimidex with Faslodex;   Drug: Arimidex without Faslodex
8 Recruiting Young-Onset Microsatellite-Stable Colorectal Cancer
Conditions: Colon Cancer;   Rectal Cancer
Interventions: Behavioral: Questionnaires;   Procedure: Blood Draw
9 Recruiting Denosumab for Breast Cancer With Bone Mets
Condition: Breast Cancer
Intervention: Drug: Denosumab
10 Recruiting Nintedanib For HER2-negative Metastatic Inflammatory Breast Cancer (MIBC)
Condition: Breast Cancer
Interventions: Drug: BIBF 1120;   Behavioral: Phone Call
11 Recruiting Feasibility of Short Breast MRI (SBMRI) for Screening Patients at High Risk for Breast Cancer
Condition: Breast Cancer
Interventions: Procedure: Short Breast MRI (SBMRI);   Behavioral: Questionnaire
12 Recruiting MK-3475 for Metastatic Inflammatory Breast Cancer (MIBC)
Condition: Breast Cancer
Interventions: Drug: MK-3475;   Behavioral: Follow Up/Phone Call
13 Recruiting Genomic Testing for Primary Breast Cancer
Condition: Breast Cancer
Interventions: Procedure: Tumor Biopsy;   Other: Breast Cancer Registry
14 Recruiting Phase IIB Neoadjuvant Enzalutamide (ZT) Plus Taxol for Androgen Receptor (AR)-Positive Triple-Negative Breast Cancer (AR+ TNBC)
Condition: Breast Cancer
Interventions: Drug: Enzalutamide;   Drug: Paclitaxel
15 Recruiting Triple-Negative First-Line Study: Neoadjuvant Trial of Nab-Paclitaxel and MPDL3280A, a Pdl-1 Inhibitor in Patients With Triple Negative Breast Cancer
Condition: Breast Cancer
Interventions: Drug: MPDL3280A;   Drug: Nab-paclitaxel
16 Recruiting The Role of Lifestyle Factors in Breast Cancer-Related Outcomes
Condition: Breast Cancer
Interventions: Behavioral: Aerobic Activity;   Behavioral: Dietician Counseling;   Behavioral: Yoga;   Behavioral: Cognitive Behavior Therapy;   Behavioral: Smoking Cessation Counseling;   Behavioral: Questionnaires;   Other: Saliva Samples;   Behavioral: Dietary Assessment;   Procedure: Blood Samples
17 Recruiting Feasibility and Identification of Breast Cancer Patients for Potential Avoidance of Surgery
Condition: Breast Cancer
Intervention: Procedure: Ultrasound-Guided Biopsy
18 Recruiting Pembrolizumab in Combination With Chemotherapy in Frontline Ovarian Cancer
Conditions: Ovarian Cancer;   Metastatic Ovarian Cancer
Interventions: Drug: Carboplatin;   Drug: Paclitaxel;   Drug: Pembrolizumab
19 Recruiting CyberKnife Accelerated Hemilarynx Stereotactic Radiotherapy Study for Early-stage Glottic Larynx Cancer
Condition: Early-stage Glottic Larynx Cancer
Intervention: Radiation: CyberKnife Accelerated Hemilarynx Stereotactic Radiotherapy
20 Recruiting Ramucirumab for Advanced Pre-treated Biliary Cancers
Condition: Biliary Cancer
Intervention: Drug: Ramucirumab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.